B. C. Arcagök And B. Özkan, "Effective Risk Factors in the Development of Retinopathy of Prematurity, Screening Results and Intravitreal Ranibizumab Treatment," Haydarpaşa Numune Medical Journal , vol.61, no.3, pp.264-271, 2021
Arcagök, B. C. And Özkan, B. 2021. Effective Risk Factors in the Development of Retinopathy of Prematurity, Screening Results and Intravitreal Ranibizumab Treatment. Haydarpaşa Numune Medical Journal , vol.61, no.3 , 264-271.
Arcagök, B. C., & Özkan, B., (2021). Effective Risk Factors in the Development of Retinopathy of Prematurity, Screening Results and Intravitreal Ranibizumab Treatment. Haydarpaşa Numune Medical Journal , vol.61, no.3, 264-271.
Arcagök, Baran, And Berna ÖZKAN. "Effective Risk Factors in the Development of Retinopathy of Prematurity, Screening Results and Intravitreal Ranibizumab Treatment," Haydarpaşa Numune Medical Journal , vol.61, no.3, 264-271, 2021
Arcagök, Baran C. And Özkan, Berna. "Effective Risk Factors in the Development of Retinopathy of Prematurity, Screening Results and Intravitreal Ranibizumab Treatment." Haydarpaşa Numune Medical Journal , vol.61, no.3, pp.264-271, 2021
Arcagök, B. C. And Özkan, B. (2021) . "Effective Risk Factors in the Development of Retinopathy of Prematurity, Screening Results and Intravitreal Ranibizumab Treatment." Haydarpaşa Numune Medical Journal , vol.61, no.3, pp.264-271.
@article{article, author={Baran Cengiz ARCAGOK And author={Berna ÖZKAN}, title={Effective Risk Factors in the Development of Retinopathy of Prematurity, Screening Results and Intravitreal Ranibizumab Treatment}, journal={Haydarpaşa Numune Medical Journal}, year=2021, pages={264-271} }